Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0152030 (
skin irritation
)
2,146
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Variable types of
skin irritation
were induced in 8 human female volunteers, ranging from subclinical to visible erythema with slight oedema. Skin reactions were graded clinically and objectively using transepidermal water loss (TEWL), laser Doppler flowmetry (LDF) and improved reflectance spectroscopy. This last technique enables separation of in vivo erythemas into relatively deoxygenated (venous--deoxy hem) and oxygenated (arterial--oxy hem) haemoglobin components. Compared to uninvolved skin, an empty patch increased oxy hem by 197% +/- 121% (p < 0.05). Exposure to vehicles also changes skin biophysics. At sodium lauryl sulfate (SLS) and hydrochloric acid (HCl) exposed sites, a linear correlation between concentration and oxy hem, LDF and TEWL was found. These chemicals predominantly increased TEWL values.
Nonanoic acid
(NON) and imipramine (IMI) also raised oxy hem, LDF and TEWL values linearly at increasing concentrations. Although IMI 2.5% clinically was graded as a type ++ response, no significant increase in TEWL was found. The improved reflectance spectroscopic technique proved valid in
skin irritation
studies, with a higher sensitivity than laser Doppler flowmetry, and allowed irritant vascular reactions to be discriminated into arterial and venous components. Furthermore, our observations clearly demonstrate that clinically indistinguishable
skin irritation
reactions induce significantly different changes in barrier function (disruption) and vascular status.
...
PMID:Skin irritation in man: a comparative bioengineering study using improved reflectance spectroscopy. 856 86
The term 'anti-irritant' (AI) was coined in 1965 by Goldemberg to describe a diverse group of topical product ingredients, which were able to reduce the irritation potential of other more irritating ingredients in the same product. 'AIs' are being added to cosmetic formulations in order, allegedly, to benefit tolerability of the products and allow claims such as 'soothing' and 'healing' ingredients. Limited documentation in favour of the efficacy of AIs is published. We studied the dose-related effect of 4 alleged AIs (nifedipine, (-)-alpha-bisabolol, canola oil and glycerol) on experimentally induced acute irritation in healthy volunteers. Each AI was used in 3 concentrations. Acute irritation was induced by occlusive tests with 1% sodium lauryl sulfate and 20%
nonanoic acid
in N-propanol. The irritant reactions were treated twice daily with AI-containing formulations from the time of removal of the patches. Evaluation of
skin irritation
and efficacy of treatments were performed daily for 4 days using clinical scoring, evaporimetry (transepidermal water loss), hydration measurement and colourimetry. Only glycerol showed dose-response and effects potentially better than no treatment. There was no significant effect and no difference between the three other AIs.
...
PMID:Anti-irritants I: Dose-response in acute irritation. 1691 13